BioWorld

Oct. 25, 1995

View Archived Issues

OTHER NEWS TO NOTE

Read More

CELGENE GETS COST-RECOVERY PROGRAM FOR SYNOVIR

Read More

CYTRX PLUMMETS ON GLAXO'S EXIT FROM DRUG COLLABORATION

Read More

`SAGE' COMPARES THOUSANDS OF EXPRESSED GENES AT ONCE IN NORMAL,

Read More

GENZYME'S SEPRAFILM TRIAL DATA SHOWS STATISTICAL SIGNIFICANCE

Read More

TECHNOLOGY SHARING PART OF THE DEAL LILLY, MILLENNIUM IN $50M

Read More